Sphera Funds Management »

Rhythm Pharmaceuticals shares owned by Sphera Funds Management

Quarter-by-quarter ownership of Rhythm Pharmaceuticals (RYTM) shares owned by Sphera Funds Management from 13F filings

Historical chart of Sphera Funds Management investment in Rhythm Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Rhythm Pharmaceuticals held by Sphera Funds Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rhythm Pharmaceuticals by Sphera Funds Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $8.9M 80k 111.03

More positions owned by Sphera Funds Management

Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Biogen Idec (BIIB)
Mineralys Therapeutics (MLYS)
Tower Semiconductor Shs New (TSEM)
Cytokinetics Com New (CYTK)
Spdr Series Trust St Str Sp Biot Put Option (XBI)
Syndax Pharmaceuticals (SNDX)
Ultragenyx Pharmaceutical (RARE)
BioMarin Pharmaceutical (BMRN)
Bridgebio Pharma (BBIO)
Cogent Biosciences (COGT)
NOVA MEASURING Instruments L (NVMI)
Insmed Com Par $.01 (INSM)
Maze Therapeatics (MAZE)
Astrazeneca Ord (AZN)

View all positions for Sphera Funds Management

Top funds holding Rhythm Pharmaceuticals

RA Capital Management
BlackRock
Baker Bros. Advisors
PRIMECAP Management Company
Vanguard Portfolio Management
Vanguard Capital Management
Jpmorgan Chase & Co
Perceptive Advisors
State Street Corporation
Westfield Capital Management Company
Goldman Sachs Group
Federated Investors
Polar Capital Holdings
T. Rowe Price Associates
Geode Capital Management

View all funds holding Rhythm Pharmaceuticals